153 related articles for article (PubMed ID: 32681754)
21. Targeted Therapy Win in BRAF-Mutant Gliomas.
Cancer Discov; 2023 Nov; 13(11):2299-2300. PubMed ID: 37732735
[TBL] [Abstract][Full Text] [Related]
22. Current Salvage Treatment Strategies for Younger Children (<10 y of Age) With Progressive Low-grade Glioma After Initial Chemotherapy in North America: A Web-based Survey.
Moorman B; Barbour M; Huang MA
J Pediatr Hematol Oncol; 2021 Jan; 43(1):e141-e145. PubMed ID: 33235141
[TBL] [Abstract][Full Text] [Related]
23. BRAF-Targeted Therapy in the Treatment of
Johanns TM; Ansstas G; Dahiya S
J Natl Compr Canc Netw; 2018 Apr; 16(4):451-454. PubMed ID: 29632063
[No Abstract] [Full Text] [Related]
24. Dabrafenib Effective in Pediatric Glioma.
Cancer Discov; 2017 Jan; 7(1):OF5. PubMed ID: 28062673
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of the effectiveness and safety of combined procarbazine, lomustine, and vincristine as a therapeutic method for recurrent high-grade glioma: A protocol for systematic review and meta-analysis.
Cai Y; Jiang YG; Wang M; Jiang ZH; Tan ZG
Medicine (Baltimore); 2020 Sep; 99(38):e22238. PubMed ID: 32957367
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy for progressive low-grade gliomas in children older than ten years: the Dana-Farber experience.
Heath JA; Turner CD; Poussaint TY; Scott RM; Goumnerova L; Kieran MW
Pediatr Hematol Oncol; 2003; 20(7):497-504. PubMed ID: 12959854
[TBL] [Abstract][Full Text] [Related]
27. Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation.
Dodgshun AJ; SantaCruz N; Hwang J; Ramkissoon SH; Malkin H; Bergthold G; Manley P; Chi S; MacGregor D; Goumnerova L; Sullivan M; Ligon K; Beroukhim R; Herrington B; Kieran MW; Hansford JR; Bandopadhayay P
J Neurooncol; 2016 Jun; 128(2):293-302. PubMed ID: 26994902
[TBL] [Abstract][Full Text] [Related]
28. Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas.
Scheinemann K; Bartels U; Tsangaris E; Hawkins C; Huang A; Dirks P; Fried I; Bouffet E; Tabori U
Pediatr Blood Cancer; 2011 Jul; 57(1):84-8. PubMed ID: 21557457
[TBL] [Abstract][Full Text] [Related]
29. Procarbazine--a traditional drug in the treatment of malignant gliomas.
Goerne R; Bogdahn U; Hau P
Curr Med Chem; 2008; 15(14):1376-87. PubMed ID: 18537615
[TBL] [Abstract][Full Text] [Related]
30. Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.
Ater JL; Xia C; Mazewski CM; Booth TN; Freyer DR; Packer RJ; Sposto R; Vezina G; Pollack IF
Cancer; 2016 Jun; 122(12):1928-36. PubMed ID: 27061921
[TBL] [Abstract][Full Text] [Related]
31. Bevacizumab is active as a single agent against recurrent malignant gliomas.
Agha CA; Ibrahim S; Hassan A; Elias DA; Fathallah-Shaykh HM
Anticancer Res; 2010 Feb; 30(2):609-11. PubMed ID: 20332478
[TBL] [Abstract][Full Text] [Related]
32. Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02.
Prabhu RS; Won M; Shaw EG; Hu C; Brachman DG; Buckner JC; Stelzer KJ; Barger GR; Brown PD; Gilbert MR; Mehta MP
J Clin Oncol; 2014 Feb; 32(6):535-41. PubMed ID: 24419119
[TBL] [Abstract][Full Text] [Related]
33. Regimen of procarbazine, lomustine, and vincristine versus temozolomide for gliomas.
Wick W; Winkler F
Cancer; 2018 Jul; 124(13):2674-2676. PubMed ID: 29698549
[No Abstract] [Full Text] [Related]
34. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.
Lassaletta A; Zapotocky M; Mistry M; Ramaswamy V; Honnorat M; Krishnatry R; Guerreiro Stucklin A; Zhukova N; Arnoldo A; Ryall S; Ling C; McKeown T; Loukides J; Cruz O; de Torres C; Ho CY; Packer RJ; Tatevossian R; Qaddoumi I; Harreld JH; Dalton JD; Mulcahy-Levy J; Foreman N; Karajannis MA; Wang S; Snuderl M; Nageswara Rao A; Giannini C; Kieran M; Ligon KL; Garre ML; Nozza P; Mascelli S; Raso A; Mueller S; Nicolaides T; Silva K; Perbet R; Vasiljevic A; Faure Conter C; Frappaz D; Leary S; Crane C; Chan A; Ng HK; Shi ZF; Mao Y; Finch E; Eisenstat D; Wilson B; Carret AS; Hauser P; Sumerauer D; Krskova L; Larouche V; Fleming A; Zelcer S; Jabado N; Rutka JT; Dirks P; Taylor MD; Chen S; Bartels U; Huang A; Ellison DW; Bouffet E; Hawkins C; Tabori U
J Clin Oncol; 2017 Sep; 35(25):2934-2941. PubMed ID: 28727518
[TBL] [Abstract][Full Text] [Related]
35. Pediatric gliomas with CRAF fusions may require combination treatment.
Printz C
Cancer; 2016 Apr; 122(8):1148. PubMed ID: 27061517
[No Abstract] [Full Text] [Related]
36. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
Levin VA; Silver P; Hannigan J; Wara WM; Gutin PH; Davis RL; Wilson CB
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):321-4. PubMed ID: 2154418
[TBL] [Abstract][Full Text] [Related]
37. Rapid Clinical and Radiographic Response With Combined Dabrafenib and Trametinib in Adults With
Johanns TM; Ferguson CJ; Grierson PM; Dahiya S; Ansstas G
J Natl Compr Canc Netw; 2018 Jan; 16(1):4-10. PubMed ID: 29295876
[No Abstract] [Full Text] [Related]
38. Dabrafenib and trametinib in BRAFV600E mutated glioma.
Brown NF; Carter T; Kitchen N; Mulholland P
CNS Oncol; 2017 Oct; 6(4):291-296. PubMed ID: 28984141
[TBL] [Abstract][Full Text] [Related]
39. PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of BRAF V600E Mutational Status.
Martin AM; Bell WR; Yuan M; Harris L; Poore B; Arnold A; Engle EL; Asnaghi L; Lim M; Raabe EH; Eberhart CG
J Neuropathol Exp Neurol; 2020 Jan; 79(1):74-85. PubMed ID: 31819973
[TBL] [Abstract][Full Text] [Related]
40. BRAF Inhibition in
Kaley T; Touat M; Subbiah V; Hollebecque A; Rodon J; Lockhart AC; Keedy V; Bielle F; Hofheinz RD; Joly F; Blay JY; Chau I; Puzanov I; Raje NS; Wolf J; DeAngelis LM; Makrutzki M; Riehl T; Pitcher B; Baselga J; Hyman DM
J Clin Oncol; 2018 Dec; 36(35):3477-3484. PubMed ID: 30351999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
